Literatura científica selecionada sobre o tema "Plasmalogen lipids"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Índice
Consulte a lista de atuais artigos, livros, teses, anais de congressos e outras fontes científicas relevantes para o tema "Plasmalogen lipids".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Artigos de revistas sobre o assunto "Plasmalogen lipids"
Rothhaar, Tatjana L., Sven Grösgen, Viola J. Haupenthal, Verena K. Burg, Benjamin Hundsdörfer, Janine Mett, Matthias Riemenschneider, Heike S. Grimm, Tobias Hartmann e Marcus O. W. Grimm. "Plasmalogens Inhibit APP Processing by Directly Affectingγ-Secretase Activity in Alzheimer’s Disease". Scientific World Journal 2012 (2012): 1–15. http://dx.doi.org/10.1100/2012/141240.
Texto completo da fontePaul, Sudip, Aliki A. Rasmiena, Kevin Huynh, Adam Alexander T. Smith, Natalie A. Mellett, Karin Jandeleit-Dahm, Graeme I. Lancaster e Peter J. Meikle. "Oral Supplementation of an Alkylglycerol Mix Comprising Different Alkyl Chains Effectively Modulates Multiple Endogenous Plasmalogen Species in Mice". Metabolites 11, n.º 5 (6 de maio de 2021): 299. http://dx.doi.org/10.3390/metabo11050299.
Texto completo da fonteRüdiger, Mario, Angelika Tölle, Wolfgang Meier e Bernd Rüstow. "Naturally derived commercial surfactants differ in composition of surfactant lipids and in surface viscosity". American Journal of Physiology-Lung Cellular and Molecular Physiology 288, n.º 2 (fevereiro de 2005): L379—L383. http://dx.doi.org/10.1152/ajplung.00176.2004.
Texto completo da fonteBozelli, José Carlos, e Richard M. Epand. "Plasmalogen Replacement Therapy". Membranes 11, n.º 11 (29 de outubro de 2021): 838. http://dx.doi.org/10.3390/membranes11110838.
Texto completo da fonteNAGAN, Narasimhan, Amiya K. HAJRA, Leslie K. LARKINS, Paul LAZAROW, Edward PURDUE, William B. RIZZO e Raphael A. ZOELLER. "Isolation of a Chinese hamster fibroblast variant defective in dihydroxyacetonephosphate acyltransferase activity and plasmalogen biosynthesis: use of a novel two-step selection protocol". Biochemical Journal 332, n.º 1 (15 de maio de 1998): 273–79. http://dx.doi.org/10.1042/bj3320273.
Texto completo da fonteWerner, Ernst R., Markus A. Keller, Sabrina Sailer, Katharina Lackner, Jakob Koch, Martin Hermann, Stefan Coassin et al. "TheTMEM189gene encodes plasmanylethanolamine desaturase which introduces the characteristic vinyl ether double bond into plasmalogens". Proceedings of the National Academy of Sciences 117, n.º 14 (24 de março de 2020): 7792–98. http://dx.doi.org/10.1073/pnas.1917461117.
Texto completo da fonteGallego-García, Aránzazu, Antonio J. Monera-Girona, Elena Pajares-Martínez, Eva Bastida-Martínez, Ricardo Pérez-Castaño, Antonio A. Iniesta, Marta Fontes, S. Padmanabhan e Montserrat Elías-Arnanz. "A bacterial light response reveals an orphan desaturase for human plasmalogen synthesis". Science 366, n.º 6461 (3 de outubro de 2019): 128–32. http://dx.doi.org/10.1126/science.aay1436.
Texto completo da fonteTheiss, Elena Leoni, Lea Victoria Griebsch, Anna Andrea Lauer, Daniel Janitschke, Vincent Konrad Johannes Erhardt, Elodie Christiane Haas, Konstantin Nicolas Kuppler et al. "Vitamin B12 Attenuates Changes in Phospholipid Levels Related to Oxidative Stress in SH-SY5Y Cells". Cells 11, n.º 16 (18 de agosto de 2022): 2574. http://dx.doi.org/10.3390/cells11162574.
Texto completo da fontePerez, Marcos A., Andrea J. Clostio, Isabel R. Houston, Jimena Ruiz, Leslie Magtanong, Scott J. Dixon e Jennifer L. Watts. "Ether lipid deficiency disrupts lipid homeostasis leading to ferroptosis sensitivity". PLOS Genetics 18, n.º 9 (30 de setembro de 2022): e1010436. http://dx.doi.org/10.1371/journal.pgen.1010436.
Texto completo da fonteLoidl-Stahlhofen, A., K. Hannemann, R. Felde e G. Spiteller. "Epoxidation of plasmalogens: source for long-chain α-hydroxyaldehydes in subcellular fractions of bovine liver". Biochemical Journal 309, n.º 3 (1 de agosto de 1995): 807–12. http://dx.doi.org/10.1042/bj3090807.
Texto completo da fonteTeses / dissertações sobre o assunto "Plasmalogen lipids"
Schmitt, Iris Maria. "The role of plasmalogen ether lipids in the metabolic syndrome". Thesis, University of Cambridge, 2013. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.648371.
Texto completo da fonteWu, Yu. "Neuroprotective liquid crystalline cubosome and hexosome nanoparticle formulations by self-assembly of plasmalogen lipids and a neurotrophic peptide". Electronic Thesis or Diss., université Paris-Saclay, 2024. http://www.theses.fr/2024UPASQ003.
Texto completo da fonteThe primary aim of this thesis is to investigate the neuroprotective effect of plasmalogens (Pls) and explore the potential of lipid nanoparticles against neurodegenerative diseases. Our strategy aims to create a self-assembled system, enhancing the efficacy of plasmalogens and the neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) for neuroprotection. The Pls, a distinctive group of membrane glycerophospholipids, typically contain a polyunsaturated fatty acyl chain at the sn-2 position and an alkyl chain linked by a vinyl-ether bond at the sn-1 position of the glycerol backbone. Pls, with their unique structure featuring a vinyl ether bond, possess free radical scavenging capabilities and antioxidant properties. Addressing the decline in plasmalogen levels in aging individuals holds promise for therapies related to Parkinson's disease, Alzheimer's disease, and dementia. Recent research has expanded our understanding of their antioxidant effects, anti-inflammation, and their involvement in ferroptosis. However, challenges persist in implementing plasmalogens in treatments of neurodegenerative diseases and in developing suitable drug delivery systems. We summarize the progress in lipid nanoparticles (LNPs) for targeting multiple neurodegeneration mechanisms. Our research on plasmalogen-loaded LNPs explores their fabrication mechanism and in vitro/in vivo impacts on neurodegenerative models. Our study shows the feasibility of enhancing Pls efficacy using LNPs as carriers. We employ natural plasmalogens from scallops to create nanoformulations involving a non-lamellar lipid excipient (MO) for structural stabilization, various surfactants, and small amounts of vitamin E, curcumin, or coenzyme Q10. Using small-angle X-ray scattering (SAXS), we identified the structural features of various LNPs (vesicles, cubosomes, and hexosomes). Our in vitro evaluations utilized human neuroblastoma SH-SY5Y cells, differentiated with 10 µM retinoic acid for 5 days. Cell viability tests indicated non-toxicity of the LNPs at a total lipid concentration of 10 µM for 24-hour incubation. We study the impact of Pls nanoparticles on an in vitro model of Parkinson's disease using neuronal cells induced by the neurotoxin 6-OHDA. Using the SH-SY5Y cell line, we explore cellular damage mechanisms (oxidative stress and apoptotic enzymes) via identifying the impact on the ERK-Akt-CREB-BDNF signaling pathway. Several documented neuroprotective compounds were used to demonstrate the ability to restore neuronal lesions caused by 6-OHDA, offering a model of neurodegenerative conditions to further elucidate the beneficial effects of the Pls-based LNPs. We then focus on the cAMP response element binding protein (CREB) and its phosphorylation leading to neurotrophin expression, crucial in preventing neurological disorders. Through lipid peptide nano-assemblies, we studied the impact of different structural organizations of the LNPs on CREB phosphorylation in an in vitro model of Parkinson's disease. Notably, liquid crystalline lipid nanoparticles loaded with plasmalogens prolonged CREB activation under neurodegenerative conditions, showing potential for enhanced neuroregeneration through sustained CREB activation in response to the neurotrophic nanoassemblies. In a mouse model of Parkinson's disease, vesicle and hexosome LNPs demonstrated distinct effectiveness in restoring motor function. The nanomedicine-mediated intervention influenced Parkinson's disease-related gene regulation and rebalanced lipid profiles. Nasal administration of Pls-loaded LNPs improved disease behavioral symptoms and downregulated genes like IL33 and Tnfa. The obtained results indicated the significant impact of hexosomal LNP nanomedicines on disease attenuation, lipid metabolism, and responsive gene modifications potentially involved in regeneration
Calhoon, Elisabeth Ann. "Lipids of mitochondria in fibroblasts and their nexus to life history in temperate and tropical birds". The Ohio State University, 2011. http://rave.ohiolink.edu/etdc/view?acc_num=osu1306866847.
Texto completo da fonteAbou-Zaid, Anas Mamdouh. "On the Prevalence and Role of Addition Reactions in Lipid Peroxidation". Thesis, Université d'Ottawa / University of Ottawa, 2021. http://hdl.handle.net/10393/42411.
Texto completo da fonteCalhoon, Elisabeth A. "Lipid class and phospholipid species composition associated with life history variation in north temperate and neotropical birds". The Ohio State University, 2016. http://rave.ohiolink.edu/etdc/view?acc_num=osu1450091613.
Texto completo da fonteLivros sobre o assunto "Plasmalogen lipids"
Snyder, Fred. Ether Lipids Chemistry and Biology. Elsevier Science & Technology Books, 2012.
Encontre o texto completo da fonteCapítulos de livros sobre o assunto "Plasmalogen lipids"
Scherrer, Linda A., e Richard W. Gross. "Subcellular distribution, molecular dynamics and catabolism of plasmalogens in myocardium". In Lipid Metabolism in Normoxic and Ischemic Heart, 97–105. Boston, MA: Springer US, 1989. http://dx.doi.org/10.1007/978-1-4613-1611-4_15.
Texto completo da fonteHorrocks, L. A., H. W. Harder, R. Mozzi, G. Goracci, E. Francescangeli, S. Porcellati e G. G. Nenci. "Receptor-Mediated Degradation of Choline Plasmalogens and Glycerophospholipid Methylation: A New Hypothesis". In Enzymes of Lipid Metabolism II, 707–11. Boston, MA: Springer US, 1986. http://dx.doi.org/10.1007/978-1-4684-5212-9_85.
Texto completo da fonteTakama, Kozo, Kazuaki Kikuchi e Tetsuya Suzuki. "Marine Plasmalogen and its Antioxidative Effect Intake of Dietary Fish Oil into Membrane Lipid and Their Stability Against Oxidative Stress". In ACS Symposium Series, 58–65. Washington, DC: American Chemical Society, 1998. http://dx.doi.org/10.1021/bk-1998-0702.ch007.
Texto completo da fonte"Assay and Purification of Plasmalogen-Selective Phospholipase A2 and Lysoplasmalogenase Activities". In Metabolism and Functions of Bioactive Ether Lipids in the Brain, 67–83. New York, NY: Springer New York, 2008. http://dx.doi.org/10.1007/978-0-387-77401-5_4.
Texto completo da fonteFarooqui, Akhlaq A., e Lloyd A. Horrocks. "Plasmalogens, platelet-activating factor, and other ether glycerophospholipids". In Bioactive Lipids, 107–34. Elsevier, 2012. http://dx.doi.org/10.1533/9780857097934.107.
Texto completo da fonte"Biosynthesis of Plasmalogens in Brain". In Metabolism and Functions of Bioactive Ether Lipids in the Brain, 17–37. New York, NY: Springer New York, 2008. http://dx.doi.org/10.1007/978-0-387-77401-5_2.
Texto completo da fonte"Catabolism of Plasmalogens in Brain". In Metabolism and Functions of Bioactive Ether Lipids in the Brain, 39–65. New York, NY: Springer New York, 2008. http://dx.doi.org/10.1007/978-0-387-77401-5_3.
Texto completo da fonte"Roles of Plasmalogens in Brain". In Metabolism and Functions of Bioactive Ether Lipids in the Brain, 85–106. New York, NY: Springer New York, 2008. http://dx.doi.org/10.1007/978-0-387-77401-5_5.
Texto completo da fonteVentura, Raúl, e María Isabel Hernández-Alvarez. "Endoplasmic Reticulum: A Hub in Lipid Homeostasis". In Updates on Endoplasmic Reticulum [Working Title]. IntechOpen, 2022. http://dx.doi.org/10.5772/intechopen.105450.
Texto completo da fonte"Involvement of Plasmalogens in Neurological Disorders". In Metabolism and Functions of Bioactive Ether Lipids in the Brain, 107–27. New York, NY: Springer New York, 2008. http://dx.doi.org/10.1007/978-0-387-77401-5_6.
Texto completo da fonteTrabalhos de conferências sobre o assunto "Plasmalogen lipids"
Giuffrida, Francesca. "Identification of glycerophospholipid species in food and biological matrices by supercritical fluid chromatography coupled with high resolution mass spectrometry". In 2022 AOCS Annual Meeting & Expo. American Oil Chemists' Society (AOCS), 2022. http://dx.doi.org/10.21748/jihg7525.
Texto completo da fonteSturk, A., M. C. L. Schaap, A. Prins Heymans, J. W. ten Cate, R. J. A. Wanders, H. S. A. Heymans, R. B. H. Schutgens e H. van den Bosch. "SEVERELY IMPAIRED SYNTHESIS OF PLATELET ACTIVATING FACTOR IN CHONDRO DYSPLASIA PUNCTATA RHIZOMELIA PATIENTS". In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1642883.
Texto completo da fonte